Keyphrases
Diabetes Prevention
100%
Dendritic Cells
100%
Nuclear Transcription Factor
100%
Transcription Factor B
100%
Non-obese Diabetic Mice
100%
Oligodeoxynucleotide
63%
Diabetes
18%
Islet
9%
T Cells
9%
Autoimmune Diabetes
9%
Specific Inhibition
9%
Interleukin-2
9%
Type 1 Diabetic Patient
9%
Interferon-α (IFN-α)
9%
Immunostimulatory
9%
Islet Antigens
9%
Hyporesponsiveness
9%
DNA Binding
9%
Immunogenic
9%
Lipopolysaccharide Stimulation
9%
Interleukin-12 (IL-12)
9%
Preventive Strategies
9%
Cell nuclear Extracts
9%
Low Production
9%
Gel Shift Assay
9%
B-DNA
9%
Mouse Bone Marrow
9%
Associated Antigen
9%
Pancreatic Lymph Nodes
9%
Costimulatory Molecules
9%
Diabetes Development
9%
Medicine and Dentistry
Diabetes
100%
Diabetes Mellitus
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Transcription Factors
100%
Dendritic Cell
100%
Oligodeoxyribonucleotide
63%
T Cell
9%
In Vitro
9%
Autoimmune Diabetes
9%
DNA Binding
9%
Gamma Interferon
9%
Interleukin 12
9%
DNA B
9%
Pancreatic Lymph Node
9%
Interleukin 2
9%
Lipopolysaccharide
9%
Diseases
9%
Electrophoretic Mobility-Shift Assay
9%
Immunology and Microbiology
Dendritic Cell
100%
Complement Factor B
100%
Nonobese Diabetic Mouse
100%
Transcription Factors
100%
Autoimmune Diabetes
9%
Interleukin 2
9%
Extract
9%
DNA Binding
9%
Pancreatic Lymph Node
9%
T Cell
9%
Interferon Gamma
9%
Interleukin 12
9%
Electrophoretic Mobility-Shift Assay
9%
In Vitro
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nonobese Diabetic Mouse
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Transcription Factors
100%
Oligodeoxyribonucleotide
63%
Lipopolysaccharide
9%
Gamma Interferon
9%
DNA B
9%
Interleukin 12
9%
Interleukin 2
9%
Diabetes Mellitus
9%
Diseases
9%